Crwenewswire Highlights - Pwrm, Cvat, Erx, Aqnm

PRLog (Press Release) - Aug 03, 2009 -
Las Vegas - CRWENewswire.com is pleased to announce a stock highlight on Power3 Medical Products, Inc. (OTCBB:PWRM), Xerox Corporation (NYSE: XRX, Cavitation Technologies, Inc. CVAT.OB, Aquentium (OTCBB:AQNM)

Power3 Medical Products, Inc. (OTCBB:PWRM) (www.power3medical.com), announced today that the Company has filed a patent for Diagnosis of Early Stage Parkinsons Disease: Abnormal: Blood Serum Concentrations of a Select Group of Protein Biomarkers.

Xerox Corporation (NYSE: XRX) digital production color devices account for more than 50 percent of the total worldwide page volume1 – and now print providers have another option for their digital printing needs with the launch of the Xerox DocuColor® 7002/8002 Digital Presses.

Power3 Medical Products, Inc. filed a provisional patent on the diagnosis of early stage Parkinsons disease: abnormal blood serum concentrations of a select group of protein biomarkers. This not only announces to the industry the progress of the Nuro-Pro-PD test for Parkinsons, in validation, utility, but that the importance of the Power3 protein biomarkers are statistically valid for use as a diagnostic test. This work was done in conjunction with Transgenomic, Inc. license/collaboration agreement. The patent provides coverage of biomarkers and the computation/statistical methods used to discriminate the disease vs. the normal controls.

Cavitation Technologies, Inc. CVAT.OB commented that since its last announcement concerning its chemical free "Green D+ Plus Degumming" (GPD) technology they have had a huge response from around the world with interest in installing the GPD technology.

CTI's new GPD system is based on its patent-pending flow-through Nano Cavitation Reactor technology that promotes the formation, growth, and implosive collapse of gas or vapor-filled bubbles in liquids. The process involves the mixing of crude vegetable oil and water and exposing them to high-pressure impulses and micro explosions at the molecular level causing the gums to become denser thus allowing efficient separation and higher oil yields.

Xerox Corporation (NYSE: XRX - News) digital production color devices account for more than 50 percent of the total worldwide page volume1 – and now print providers have another option for their digital printing needs with the launch of the Xerox DocuColor® 7002/8002 Digital Presses.

Aquentium (OTCBB:AQNM) announced to day that the company has begun its feasibility study for implementation of a waste-to-energy plant in the country of South Korea.


About Power3 Medical Products, Inc.

Power3 Medical Products, Inc. (OTCBB:PWRM) (www.Power3Medical.com), is a leading Bio Medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets.
Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. The Company continues to evolve and enhance its IP portfolio.

About Cavitation Technologies

Cavitation Technologies, Inc. (CTI); (OTC: CVAT - News); is a "Green-Tech" company, established in 2006 to become a world leader in the development and licensing of new cutting edge technologies for the, biodiesel, vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, petroleum, food and beverage, and chemical industries. Our mission is to apply our technology in order to make the world better through renewable energy. For more information please visit our website: www.cavitationtechnologies.com

About Xerox Corporation Inc.
Xerox Corporation engages in the development, manufacture, marketing, servicing, and financing of document equipment, software, solutions, and services worldwide.

Aquentium (OTCBB:AQNM) announced to day that the company has begun its feasibility study for implementation of a waste-to-energy plant in the country of South Korea. The study is based on building a 1,000 metric ton per day waste to energy processing plant.

About Aquentium
Aquentium is a diversified company with an emphasis on green technologies. The company currently has interests in non-chemical sanitation equipment, waste-to-energy technologies, water treatment, food safety, mining, alternative energy, building materials, affordable housing, re-deployable housing, and recycling.


Forward Looking Statement

This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement.

Sign up to receive FREE Stock-PR alerts from CRWENewswire.com at http://www.crwenewswire.com/?p=2546


About CRWENewswire.com

CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.
CRWENewswire.com is not a registered investment advisor or broker-dealer. CRWENewswire.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

We encourage investors to join and receive CRWENewswire.com FREE e-mail news and stock watch alerts at http://www.crwenewswire.com/?p=2546 and view our full disclaimer.